Dr. Kris Alan Levengood, MD

Dr. Levengood practices at St Lukes University Hospital Bethlehem in Bethlehem, Pennsylvania.

Dr. Levengood's NPI, 1063949758, was assigned on May 12, 2017. Dr. Levengood graduated from Drexel University College of Medicine in 2017. Dr. Levengood holds Pennsylvania license MD478087.

Dr. Levengood's primary practice is St Lukes University Hospital Bethlehem, at 801 Ostrum St, Bethlehem, PA 18015 in Northampton County. The practice phone is (610) 954-4000.

Dr. Levengood's primary practice is St Lukes University Hospital Bethlehem in Bethlehem, Pennsylvania. Dr. Levengood is also affiliated with St. Luke's University Hospital - Bethlehem Campus. The medical group on file is St. Luke's South Mountain Family Practice. Dmand AI also links Dr. Levengood to 3 more hospitals and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Levengood practices, 4 sites in all. Vendor and product names are available with a free account.

Anesthesiology is Dr. Levengood's primary specialty in the NPI Registry, under taxonomy code 207L00000X. Dmand AI has Dr. Levengood's licenses on file in 2 states: Pennsylvania and California.

CMS data shows 293 Medicare services from Dr. Levengood across 15 procedure codes in 2024, for 327 Medicare patients. Medicare paid $19,518 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 327 Medicare patients who saw Dr. Levengood in 2024. The largest group is 65 to 74, with 158 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 9% are also on Medicaid. Their average risk score is 1.68, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Levengood's median patient age at 57, with 59% women.

In 2020, Dr. Levengood wrote 16 Medicare Part D claims. Every claim was for a generic drug. They cover 1 drug, with $297 in total drug cost. In 2019, CMS named 11 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 97 out of 100 for Dr. Levengood for performance year 2024, reported through an alternative payment model (APM). Dr. Levengood accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 8 general payments to Dr. Levengood from 2 drug and device companies from 2023 to 2025. Travel and lodging make up the largest share, 74% of the total. Pacira Pharmaceuticals Incorporated paid the most, $1,026.

Dr. Levengood graduated from Drexel University College of Medicine in 2017.